跳至主要内容
临床试验/NCT02520414
NCT02520414已完成不适用

A Pilot Study to Assess the Feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an Office Environment

Minerva Surgical, Inc.2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
Safety Profile of the Symphion® Bipolar Hysteroscopic Tissue Resection System When Used in the Office Setting for the Removal of Intracavitary Polyps and Myomas.

研究概览

简要总结

The purpose of this study is to determine the safety and feasibility of using the Symphion system in an office setting.

详细描述

The purpose is to determine the safety and feasibility of using an intrauterine tissue resection system in the office setting, as well as to expand the national discussion regarding in-office hysteroscopic procedures as it relates to the highest standards of care and cost containment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects must meet the approved Instructions for Use for the Symphion® bipolar hysteroscopic tissue resection system
  • Confirmation hysteroscopic evaluation to access appropriate pathology type and size meets the Protocol guidelines for inclusion
  • Subject has signed written Informed Consent

排除标准

  • Subjects who are pregnant
  • Subjects who have an active genital tract infection (as assessed by the physician)
  • Subjects who have cervical malignancies
  • Subjects who have previously been diagnosed with endometrial cancer
  • Subjects who have Type 2 intracavitary myomas
  • Type 0 or 1 intracavitary myoma greater than 3.0 cm

结局指标

主要结局

Safety Profile of the Symphion® Bipolar Hysteroscopic Tissue Resection System When Used in the Office Setting for the Removal of Intracavitary Polyps and Myomas.

时间窗: 2 weeks

Absence of device related adverse events, or death.

次要结局

未报告次要终点

研究者

发起方
Minerva Surgical, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验